Public health & disease

United States FDA approves form of ketamine for depression treatment

Esketamine is the first new drug treatment approved for depression in decades. Current drugs target the feel-good brain chemical serotonin, and can take weeks or months to kick in. Ketamine targets a chemical called glutamate that is thought to restore brain connections that help relieve depression.

United States FDA approves form of ketamine for depression treatment Read more